First Line Treatment Strategies in EGFRm NSCLC: Osimertinib in the Upfront Approach

First Line Treatment Strategies in EGFRm NSCLC: Osimertinib in the Upfront Approach

26^th May, 2021 | Speaker: Associate Professor Virute Sriuranpong

Document ID: SC-SSK-00395

Speaker

Associate Professor Virute Sriuranpong

Internal Medicine and Medical Oncology
Chulalongkorn University & The King
Chulalongkorn Memorial Hospital
Thailand

After the EGFR TKIs: Management of Advanced NSCLC Following Progression on EGFR TKIs

26^th May, 2021

Speaker: Professor Tony Mok

First Line Treatment Strategies in EGFRm NSCLC: EGFR TKIs-based Combination Treatment

26^th May, 2021

Speaker: Dr Nguyen Tuan Khoi

eLearning